Science abstracts on 神経変性疾患
- Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease
- Cannabinoids: Novel medicines for the treatment of Huntington’s disease
- Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington’s disease: role of CB(1) and CB(2) receptors
- Controlled clinical trial of cannabidiol in Huntington’s disease
- Prospects for cannabinoid therapies in basal ganglia disorders
- Neuroprotective properties of cannabigerol in Huntington’s Disease: Studies in R6/2 mice and 3-nitropropionate-lesioned mice
- Effects of a Sativex-like combination of phytocannabinoids on disease progression in R6/2 mice, an experimental model of Huntington's Disease
- Neurological aspects of medical use of CBD
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- CBD activates neuronal precursor genes in human gingival mesenchymal stromal cells
- Modulation of astrocyte activity by cannabidiol, a nonpsychoactive cannabinoid